PPD downgraded by William Blair
$PPD
Biotechnology: Commercial Physical & Biological Resarch
Health Care
William Blair downgraded PPD from Outperform to Market Perform
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/5/2021 | $47.50 | Neutral | Credit Suisse |